Fatty Acid-Binding Protein 4 and Risk of Type 2 Diabetes, Myocardial Infarction and Stroke: A Prospective Cohort Study | Zendy

Krasimira Aleksandrova | Zendy; Dagmar Drogan | Zendy; Cornelia Weikert | Zendy; Matthias B. Schulze | Zendy; Andreas Fritsche | Zendy; Heiner Boeing | Zendy; Tobias Pischon | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Fatty Acid-Binding Protein 4 and Risk of Type 2 Diabetes, Myocardial Infarction and Stroke: A Prospective Cohort Study

Author(s) -

Krasimira Aleksandrova,

Dagmar Drogan,

Cornelia Weikert,

Matthias B. Schulze,

Andreas Fritsche,

Heiner Boeing,

Tobias Pischon

Publication year - 2019

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2019-00477

Subject(s) - medicine , type 2 diabetes , hazard ratio , stroke (engine) , myocardial infarction , diabetes mellitus , prospective cohort study , cohort , quartile , glucose homeostasis , cardiology , endocrinology , insulin , insulin resistance , confidence interval , mechanical engineering , engineering

Adipocyte fatty acid-binding protein (FABP4) is expressed in adipose tissue and may impair glucose homeostasis and promote atherosclerotic processes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research